AFP and hepatocellular carcinoma: The CTCs detected also exhibited moderate diagnostic potential for differentiating patients with HCC from healthy individuals and patients with CHB/LC and BHL, with enhanced diagnostic efficiency if combined with a traditional serological biomarker (i.e., AFP).